Send us a text In this special episode of The Just MS Show, we explore the groundbreaking advancements in Multiple Sclerosis (MS) research that are changing lives and redefining what's possible. We cover: The paradigm shift: How B-cells—not T-cells—are the true culprits behind MS, and how this discovery has led to life-changing treatments like Ocrevus and Kesimpta. The EBV connection: Why Epstein-Barr Virus is now considered the leading cause of MS, and how this could lead to a preventative vaccine. Myelin repair therapies: From over-the-counter drugs like clemastine to next-gen breakthroughs like PIPE-307, stem cell grafts, and microglia modulation. Disease-modifying therapies (DMTs): New drugs like Tolebrutinib and CNM-Au8 that are slowing or reversing MS progression. Emerging trends: Using fMRI to track cognitive decline, the impact of mental health on fatigue, and how GLP-1 weight-loss drugs could reduce MS risk. Patient-focused care: Insights on treatment preferences, postpartum considerations, and financial relief through Medicare changes. This isn’t just another research update—it's a roadmap to what may soon be a world where MS is preventable, treatable, and even curable. This episode was made with A.I. to help 🔗 Links, resources, and more available at: justmultiplesclerosis.com 💬 Got questions or want to be interviewed? Reach out via the site. 🤖 Note: This episode was produced with the assistance of AI tools for research, scripting, and post-production. Human oversight ensured accuracy, clarity, and compassion throughout. At The Just MS Show, we use AI to make powerful MS content accessible, consistent, and community-driven. The Just MS (Multiple Sclerosis) Show, w host Justin Loizos, is a podcast that connects, educates and tries to uplift others living with multiple sclerosis. It provides real-life stories, interviews, and information about DMTs (disease modification therapies) and updates on research developments. www.justmultiplesclerosis.com
